Experts see improvements with bypass liner in diabetes

02/1/2013 | Medscape (free registration)

Moderately obese type 2 diabetes patients who used a duodenal-jejunal bypass liner attained significant reductions in fasting plasma glucose and A1C levels and body weight at 52 weeks, a study in the Journal of Clinical Endocrinology and Metabolism indicated. Researchers also noted lower bad cholesterol and triglyceride rates in patients.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC